A Delaware federal court has entered a $245.2m judgment in favor of TwinStrand Biosciences in a patent infringement case ...
The decision comes as FDA employees face an already strained compensation environment and President Trump this week ...
Roivant’s Priovant subsidiary gained US approval of brepocitinib in dermatomyositis. Priovant is pursuing additional ...
The Rare Disease Endpoint Advancement and Model-Informed Drug Development programs eventually will drop participation limits ...
The firm has revealed the extent of the win seen in the ACACIA-HCM study in patients with symptomatic non-obstructive ...
The 800,000-patient cluster-randomized confirmatory trial required for mFlusiva's accelerated approval in adults 65 and older ...
The FDA approved the drug for lowering the risk of cardiovascular events, but it already has a wide lead over its rival, Novo ...
Adapting to the challenges of Most Favored Nation pricing is a top priority in biopharma boardrooms, though the pricing gulf ...
Combining long reads with AI, pangenome references and diploid assembly could dramatically improve genetic disease diagnosis, ...
Axendia: 63% Of Life Science Pros Expect AI Spending To Rise In 2027 Despite ‘Poor’ Data Quality
A survey of 194 life sciences and medtech professionals showed that 63% expect AI investments to rise in 2027 with the ...
Japan's latest batch of approval recommendations include global-first nods for anselamimab for kappa light chain amyloidosis ...
Indian firms lead Paragraph IV filings in the US as a wave of blockbuster drugs lose exclusivity between 2026-2028, but the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results